This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 113/7/995    most recent CIRCULATIONAHA.105.583351v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhao, W. Articles by Kranias, E. G. Search for Related Content PubMed PubMed Citation Articles by Zhao, W. Articles by Kranias, E. G. Related Collections Contractile function Animal models of human disease Calcium cycling/excitation-contraction coupling Gene expression Gene regulation Genetically altered mice Hypertrophy

(Circulation. 2006;113:995-1004.)
© 2006 American Heart Association, Inc.

Molecular Cardiology

The Presence of Lys27 Instead of Asn27 in Human Phospholamban Promotes Sarcoplasmic Reticulum Ca²⁺-ATPase Superinhibition and Cardiac Remodeling

Wen Zhao, MD, PhD; Qunying Yuan, MD; Jiang Qian, MD; Jason R. Waggoner, PhD; Anand Pathak, PhD; Guoxiang Chu, MD, PhD; Bryan Mitton, BS; Xiaoyin Sun, MD; Jay Jin, BS; Julian C. Braz, PhD; Harvey S. Hahn, MD; Yehia Marreez, MD; Faisal Syed, MD; Piero Pollesello, PhD; Arto Annila, PhD; Hong-Sheng Wang, PhD; Jo El J. Schultz, PhD; Jeffery D. Molkentin, PhD; Stephen B. Liggett, MD; Gerald W. Dorn, II, MD; Evangelia G. Kranias, PhD

From the Departments of Pharmacology & Cell Biophysics (W.Z., Q.Y., J.Q., J.R.W., A.P., G.C., B.M., X.S., J.J., J.C.B., H.-S.W., J.E.J.S., E.G.K.), Internal Medicine (H.S.H., Y.M., F.S., G.W.D.), and Medicine (S.B.L.), University of Cincinnati College of Medicine, Cincinnati, Ohio; Department of Pediatrics (J.C.B., J.D.M.), University of Cincinnati, Children Hospital Medical Center, Cincinnati, Ohio; Cardiovascular Research (P.P.), Orion Pharma, Espoo, Finland; and Department of Physical Sciences (A.A.), University of Helsinki, Helsinki, Finland.

Correspondence to Evangelia G. Kranias, PhD, Academy of Athens, Foundation of Biomedical Research, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575. E-mail Litsa.Kranias{at}uc.edu

Received August 16, 2005; revision received December 6, 2005; accepted December 14, 2005.

Background— Phospholamban (PLN) is an inhibitor of the Ca²⁺ affinity of sarcoplasmic reticulum (SR) Ca²⁺-ATPase (SERCA2). The amino acid sequence of PLN is highly conserved, and although all species contain asparagine (Asn), human PLN is unique in containing lysine (Lys) at amino acid 27.

Methods and Results— Human PLN was introduced in the null background. Expression of human PLN, at similar levels to mouse wild-type PLN, resulted in significant decreases in the affinity of SERCA2 for Ca²⁺, attributed to unique spatial conformation of this PLN form and increases in its monomeric active unit compared with mouse PLN. The increased inhibition by human PLN was associated with attenuated cardiac contractility in the intact-animal, organ, and cardiomyocyte levels and with depressed calcium kinetics. These inhibitory effects could not be fully reversed even on maximal isoproterenol stimulation. There were no alterations in the expression levels of SERCA2, calsequestrin, ryanodine receptor, and FKBP12, although the sodium/calcium exchanger and the L-type Ca²⁺ channel expression levels were upregulated. The depressed function resulted in increased heart/body weight ratios and phosphorylation levels of Akt, p38, and Erk1/2.

Conclusions— Human PLN may play a more inhibitory role than that of other species in Ca²⁺ cycling. Expression of human PLN in the mouse is compensated by alterations in Ca²⁺-handling proteins and cardiac remodeling in an effort to normalize cardiac contractility. Thus, the unique amino acid sequence of human PLN may be critical in maintaining a high cardiac reserve, which is of paramount importance in the regulation of human cardiac function.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				W. Zhao, J. R. Waggoner, Z.-G. Zhang, C. K. Lam, P. Han, J. Qian, P. M. Schroder, B. Mitton, A. Kontrogianni-Konstantopoulos, S. L. Robia, et al. The anti-apoptotic protein HAX-1 is a regulator of cardiac function PNAS, December 8, 2009; 106(49): 20776 - 20781. [Abstract] [Full Text] [PDF]

				Q. Yuan, P. Han, M. Dong, X. Ren, X. Zhou, S. Chen, W. K. Jones, G. Chu, H.-S. Wang, and E. G. Kranias Partial downregulation of junctin enhances cardiac calcium cycling without eliciting ventricular arrhythmias in mice Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1484 - H1490. [Abstract] [Full Text] [PDF]

				L. Suckau, H. Fechner, E. Chemaly, S. Krohn, L. Hadri, J. Kockskamper, D. Westermann, E. Bisping, H. Ly, X. Wang, et al. Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy Circulation, March 10, 2009; 119(9): 1241 - 1252. [Abstract] [Full Text] [PDF]

				J. P. Schmitt, F. Ahmad, K. Lorenz, L. Hein, S. Schulz, M. Asahi, D. H. MacLennan, C. E. Seidman, J.G. Seidman, and M. J. Lohse Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca2+-ATPase Inhibition Circulation, January 27, 2009; 119(3): 436 - 444. [Abstract] [Full Text] [PDF]

				Q. Yuan, G.-C. Fan, M. Dong, B. Altschafl, A. Diwan, X. Ren, H. H. Hahn, W. Zhao, J. R. Waggoner, L. R. Jones, et al. Sarcoplasmic Reticulum Calcium Overloading in Junctin Deficiency Enhances Cardiac Contractility but Increases Ventricular Automaticity Circulation, January 23, 2007; 115(3): 300 - 309. [Abstract] [Full Text] [PDF]